Neuropathological Interactions Between COVID-19 and ADRD (R01)

This grant aims to solicit applications that propose studies in animal, cell culture, and/or human tissue models to elucidate the mechanisms by which COVID-19 interacts with and/or modulates ADRD-relevant phenotypes. The grant intends to support studies that are  disease mechanistic in nature and must incorporate ADRD outcomes, risk factors, pathologies, or relevant comorbidities. 

Funding: $500,000 per year 

Duration: 5 years

Research Authority due date: 20.8.24

LOI (encouraged) due date: 4.9.24

Full proposal due date: 4.10.24